Incidence of atazanavir- associated adverse drug reactions in second -line drugs treated south Indian HIV-1 infected patients

BACKGROUND: Ritonavir-boosted atazanavir (ATV/r) is the preferred second-line protease inhibitor (PI) option for HIV patients in resource-limited settings; its pattern of adverse drug reactions (ADRs) has not been much reported from India; hence, in this study, we have analyzed the incidence of ATV/...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Indian J Pharmacol
Main Authors: Subashini, Dhakshinamoorthy, Dinesha, Thongadi Ramesh, Boobalan, Jayaseelan, Samuel, Lawrence Christopher, Poongulali, Selvamuthu, Pradeep, Ambrose, Solomon, Sunil Suhas, Solomon, Suniti, Balakrishnan, Pachamuthu, Saravanan, Shanmugam
Formato: Artigo
Idioma:Inglês
Publicado em: Medknow Publications & Media Pvt Ltd 2016
Assuntos:
Short Communication
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5051255/
https://ncbi.nlm.nih.gov/pubmed/27721547
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/0253-7613.190759
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados